| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.26 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.26 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-08 |